Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Cerecor Inc.

Report initial data from the CERC-006 proof-of-concept study in lymphatic malformations

Not delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
8 Mar 2021
Due
30 Jun 2021
Checked
27 Oct 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Initial data anticipated from proof-of-concept study in the second quarter of 2021.”
  • SourceCerecor Inc. Form 8-K press release, 2021-03-08
  • FilingSEC filing index
  • Deadline as statedin the second quarter of 2021
  • Deadline used30 Jun 2021, the last day of the stated period
  • TypeProject
  • Permanent referenceKI-C-2021-AVTX-025367
    Cite as https://keptindex.org/c/KI-C-2021-AVTX-025367/ — this address never changes.

What we found

Evidence strength A What the grades mean

Later 8-Ks from July 26 and August 2, 2021 show CERC-006 initial data was still anticipated, now in the third quarter of 2021, after the second-quarter deadline.

  • A
    Cerecor Inc. 8-K filed 2021-07-26 Regulatory filing · published 26 Jul 2021 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “CERC-006 two dose groups: 0.5 mg and 1mg twice daily 4-week treatment Initial data anticipated 3Q 2021” ✓ confirmed on the page
  • A
    Cerecor Inc. 8-K filed 2021-07-26 Regulatory filing · published 26 Jul 2021 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “CERC-006+ Dual mTOR inhibitor Complex Lymphatic Malformations Initial Data 3Q 2021” ✓ confirmed on the page
  • A
    Cerecor Inc. 8-K filed 2021-08-02 Regulatory filing · published 2 Aug 2021 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “◦Initial data anticipated from the Phase 1b proof-of-concept clinical study in the third quarter of 2021.” ✓ confirmed on the page

Checked 27 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
Initial data from CERC-006 proof-of-concept study
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Cerecor Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-AVTX-025367 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.